| "Funding Life Sciences 2004: The Brave New World" Life Sciences Industry Council (LINC) & Orange Coast Venture Group joint breakfast program. Half of all the venture capital dollars invested in OC-based companies last year went into the healthcare sector. There has also been a noticeable acceleration in successful exits for healthcare companies via acquisitions and IPOs. What are the key factors driving the growth and success of SoCal healthcare companies? What are today's best funding and liquidity strategies for venture and post-venture stage healthcare companies? Featuring Chuck Adams, Morgan Stanley Healthcare Investment Banking Group; Jay Hagan, AMGEN Inc.; Kevin O'Boyle, NuVasive, Inc.; Charles Warden, Versant Ventures; Moderator Bob Hovee, OCVG and LINC. See http://www.ocvg.com |
RSS